The PE Ratio as of November 2024 (TTM) for Vir Biotechnology, Inc. (VIR) is -1.81

According to Vir Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.81. This represents a change of -37.81% compared to the average of -2.91 of the last 4 quarters.

Vir Biotechnology, Inc. (VIR) Historical PE Ratio (quarterly & annually)

How has VIR PE Ratio performed in the past?

The mean historical PE Ratio of Vir Biotechnology, Inc. over the last ten years is -5.00. The current -1.81 PE Ratio has changed 3.52% with respect to the historical average. Over the past ten years (40 quarters), VIR's PE Ratio was at its highest in in the June 2021 quarter at 24.88. The PE Ratio was at its lowest in in the June 2020 quarter at -37.79.

Vir Biotechnology, Inc. (VIR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vir Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vir Biotechnology, Inc. (VIR) Average PE Ratio

How has VIR PE Ratio performed in the past?

The current PE Ratio of Vir Biotechnology, Inc. (VIR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Vir Biotechnology, Inc. (VIR) PE Ratio vs. Peers

How is VIR’s PE Ratio compared to its peers?

Vir Biotechnology, Inc.’s PE Ratio is less than CureVac N.V. (5.18), greater than Reata Pharmaceuticals, Inc. (-20.07), less than Krystal Biotech, Inc. (104.40), less than Propanc Biopharma, Inc. (-0.09), greater than IVERIC bio, Inc. (-27.51), greater than Blueprint Medicines Corporation (-46.60), less than Amylyx Pharmaceuticals, Inc. (-1.38), greater than Karuna Therapeutics, Inc. (-37.08), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than Viking Therapeutics, Inc. (-58.83), greater than Intercept Pharmaceuticals, Inc. (-91.78), greater than Terns Pharmaceuticals, Inc. (-5.12), greater than Akero Therapeutics, Inc. (-9.58), greater than PTC Therapeutics, Inc. (-7.34), greater than Madrigal Pharmaceuticals, Inc. (-14.57),

Build a custom stock screener for Vir Biotechnology, Inc. (VIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vir Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vir Biotechnology, Inc. (VIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vir Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.